VAERS 2103902
GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge MN7XR
- Staat
- CO
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 07.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
Expired Dose administration; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 54-year-old female patient who received HBV (Engerix B) (batch number MN7XR, expiry date 18th January 2022) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 7th February 2022, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 7th February 2022, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The case was reported by the Medical assistant. The reporter stated that, the patient received an expired dose of Engerix B, which led to expired vaccine used. The Vaccine administration facility was the same as Primary reporter. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -